Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 26.32B | 25.96B | 26.73B | 23.12B | 18.07B |
Gross Profit | 4.31B | 3.63B | 3.65B | 2.80B | 2.65B |
EBITDA | 2.83B | 2.39B | 2.35B | 1.58B | 1.74B |
Net Income | 798.00M | 538.00M | 466.00M | 43.00M | 285.00M |
Balance Sheet | |||||
Total Assets | 33.71B | 35.25B | 32.46B | 31.25B | 27.81B |
Cash, Cash Equivalents and Short-Term Investments | 3.17B | 2.64B | 2.10B | 3.12B | 2.60B |
Total Debt | 9.09B | 11.99B | 9.49B | 9.16B | 7.71B |
Total Liabilities | 15.66B | 18.41B | 17.42B | 17.46B | 14.56B |
Stockholders Equity | 14.36B | 13.52B | 11.82B | 11.04B | 10.79B |
Cash Flow | |||||
Free Cash Flow | 3.76B | -1.29B | -1.30B | -518.00M | 1.00B |
Operating Cash Flow | 4.81B | -53.00M | -119.00M | 1.03B | 2.09B |
Investing Cash Flow | -1.03B | -1.62B | -1.15B | -1.55B | -1.10B |
Financing Cash Flow | -3.29B | 2.20B | 238.00M | 1.02B | -510.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥15.40B | 8.17 | 3.41% | -1.69% | 1.86% | ||
75 Outperform | ¥3.69B | 4.56 | 5.39% | 1.36% | 48.32% | ||
72 Outperform | ¥2.65B | 12.87 | 2.81% | 5.38% | ― | ||
68 Neutral | ¥2.68B | 9.11 | 2.75% | -11.59% | -40.79% | ||
65 Neutral | $10.86B | 15.57 | 5.28% | 1.92% | 3.13% | -27.76% | |
58 Neutral | ¥3.70B | ― | 2.38% | 0.78% | 63.89% | ||
45 Neutral | ¥2.98B | ― | 1.11% | 1.53% | -248.09% |